From January 24 to 27, 2022, CHIL attended Medlab Middle East in Dubai, engaging directly with regional leaders and laboratory professionals. Marking nearly a decade of consistent participation, the company demonstrated its capabilities in diagnostics, exchanged insights on emerging practices, and explored strategic collaborations to address evolving healthcare needs.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.